News


All News

The approval of ingenol mebutate gel presents and easy-to-use option to treat actinic keratoses (AKs), but the flexibility in dosing of a treatment like imiquimod will ensure its place in the armamentarium of AK treatments, according to the professor and chairman of the department of dermatology, Mount Sinai School of Medicine, New York.

In my early years in dermatology, there were many distinguished and acknowledged experts whose published findings became part of the core of the discipline. When they presented their findings at medical meetings or in print, one assumed that the data was valid and accurate, and it was often translated into specific management options for our patients.

On March 22, the GOP-controlled U.S. House of Representatives voted to repeal the controversial Independent Payment Advisory Board (IPAB), established by the new healthcare law now being challenged in the U.S. Supreme Court, and intended to provide a mechanism to control increasing Medicare costs. That, of course, has been sought by large numbers of physicians groups, including the American Academy of Dermatology Association.

In coming years, the trend toward less invasive technologies will continue not only in fat removal and body sculpting treatments, but also in new modalities for delivering a variety of drugs, according to physicians who spoke at MauiDerm 2012: Advances in Cosmetic and Medical Dermatology in February.

Newly available photoacoustic devices can help dermatologists identify which pigmented lesions to biopsy, according to Darrell S. Rigel, M.D., M.S. Such devices only aid the trained specialist in the assessment of such lesions, however, and do not substitute for the professional, he says.

Water-resistant sunscreen with a sun protection factor of 70 or greater can help to adequately protect people against skin cancer and photodamage, even when applied sparingly, a new study suggests.

The use of Mohs micrographic surgery (MMS) to treat nonmelanoma skin cancer (NMSC) among Medicare beneficiaries doubled from 2001 through 2006, a study published in the April issue of Archives of Dermatology reports.

Basal cell carcinoma on the ear is more frequently found in men, and is significantly more likely to be aggressive, according to a study in the May issue of the Journal of the American Academy of Dermatology.

A laser approach that selectively targets the sebaceous glands may prove to be an effective future therapy for acne, said Fernanda H. Sakamoto, M.D., Ph.D., at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.

A procedure known as Axilase that involves use of a fixed combination of 924 nm and 975 nm continuous wave laser energy can treat primary axillary hyperhidrosis, according to study data presented at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.

The use of propranolol and pulsed dye laser (PDL) led to more rapid clearing of infantile hemangiomas than propranolol alone, according to a retrospective chart review presented at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.

An aesthetic device that delivers bipolar radiofrequency (RF) energy via microneedling appears to achieve skin tightening, lifting and volumization that can be measured objectively through the comparison of pre- and post-procedure 3-D images, said Lori Brightman, M.D., at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.

Treatment with a picosecond 755 nm alexandrite laser (Cynosure) appears to be a significant advance for clearing tattoos as well as benign pigmented lesions, according to research reported at LASER 2012, the annual conference of the American Society for Laser Medicine and Surgery.

Finasteride, the main ingredient in Merck?s drugs Proscar, Propecia and generic equivalents, will now carry an expanded warning about lingering sexual side effects, the Associated Press reports.

Making the Switch : eMrs offer speed, convenience – but many derms aren’t rushing to convert How Honey Heals : Traditional remedy inhibits formation of biofilms, researchers find Special Report : Pediatric Dermatology

The hot topics of discussion at Maui Derm 2012 were January’s Food and Drug Administration approval of two innovative products in the cutaneous oncology arena: Picato (ingenol mebutate, LEO Pharma) 0.015 percent gel and 0.05 percent gel for the treatment of actinic keratoses (AKs) and Erivedge (vismodegib, Genentech) for the treatment of advanced basal cell carcinoma. At MauiDerm I discussed the data on Picato and Keith Flaherty, M.D., an oncologist from Massachusetts General Hospital, discussed Erivedge.

Implementing a few simple ideas in clinical practice can have a significant impact in terms of saving time, saving money or improving patient outcomes. During a session at the 2011 Fall Clinical Dermatology Conference, members of the faculty offered a few personal pearls, each so easy and straightforward they could be encapsulated in a one-minute description.

William Lascheid, M.D., was in his early 70s when he and his wife, Nancy, retired from four decades of dermatology practice. The couple lived in the lap of retirement luxury in Naples, Fla., and had dreamed about the days when they’d be free to sleep in and spend sunny afternoons by the pool.